Aging-Related Disease
Roughly 55 million people live with dementia worldwide; the figure is projected to reach 139 million by 2050 as populations age. Alzheimer's accounts for 60–70% of dementia cases. Parkinson's disease affects roughly 10 million people globally and is among the fastest-growing neurological conditions. Combined, neurodegenerative diseases will be the dominant burden of the demographic transition in advanced economies.
Key insights
Dementia is the leading aging-related condition
Alzheimer's disease causes 60–70% of dementia cases. Other major causes: vascular dementia (cerebrovascular damage), Lewy body dementia, frontotemporal dementia. Prevalence rises sharply with age — 5% at 65, 10% at 75, 30% at 85, 50% at 95. As life expectancy rises, exposure to high-prevalence age bands increases, multiplying total cases regardless of underlying biology.
First disease-modifying treatments are now FDA-approved
Lecanemab (full approval 2023) and donanemab (2024) are the first FDA-approved Alzheimer's drugs shown to slow disease progression rather than just treating symptoms; aducanumab (2021) came first on an accelerated basis, but its maker withdrew it in 2024. Effects are modest — roughly a quarter to a third slower cognitive decline over 18 months in trials — and access remains limited by cost, infusion requirements, and ARIA (amyloid-related imaging abnormalities) side-effects. The pipeline behind these is the largest in decades.
Asian aging will drive future case loads
Japan currently has the highest dementia prevalence (~12% of those over 65) due to its aging population. China is projected to have the largest absolute case load by 2050 (~28 million cases). Asia already has more cases than Europe and the Americas combined. Healthcare and long-term care infrastructure in many Asian countries is significantly less prepared for this than in Western Europe or North America.
Projected dementia cases 2024–2050
Millions of people, by region
Show data table
| Millions of cases | |
|---|---|
| Asia 2024 | 26 |
| Asia 2050 | 71 |
| Europe 2024 | 11 |
| Europe 2050 | 18 |
| Americas 2024 | 11 |
| Americas 2050 | 28 |
| Africa 2024 | 3 |
| Africa 2050 | 11 |
Key Finding: Total cases rise about 2.5 times by 2050; Asia shows the largest absolute growth and Africa the fastest proportional growth.
Dementia prevalence — selected countries (2024)
% of population 60+ living with dementia
Show data table
| % 60+ with dementia | |
|---|---|
| Japan | 12 |
| Italy | 8.5 |
| Germany | 7.5 |
| UK | 7.5 |
| Sweden | 7 |
| Spain | 7.2 |
| France | 6.8 |
| USA | 5.5 |
| World | 5 |
| China | 4.5 |
| Brazil | 4.3 |
| India | 3.8 |
| Nigeria | 2 |
Key Finding: Japan and Italy lead due to old populations; African countries have lower prevalence partly due to lower life expectancy.
Methodology & caveats
Diagnosis underestimates true prevalence
Many people with dementia are undiagnosed — estimates range from 40% (high-income countries) to 80% (low-income countries) of cases. Diagnosis requires cognitive testing, brain imaging, and clinical assessment that are not always accessible. Prevalence statistics partly reflect diagnostic capacity; comparisons across countries should account for this.
Prevention is starting to be possible
Lancet Commission 2024 reviewed evidence that 45% of dementia cases could be prevented or delayed by addressing 14 modifiable risk factors — less education, hearing loss, depression, head injury, hypertension, obesity, smoking, physical inactivity, diabetes, excessive alcohol, social isolation, air pollution, untreated vision loss, high cholesterol. The window for prevention is mostly midlife (40-65).
Cost calculation
Direct costs (medical care, long-term care) and indirect costs (unpaid family caregiving, lost productivity) for dementia globally are estimated at $1.3T per year. About half of total costs are informal caregiving, on WHO estimates — primarily unpaid family labor, mostly female. Aging societies face simultaneous shrinking of working-age population and rising demand for caregiver labor — the policy crunch is structural.
Why dementia counts differ
The 55 million figure comes from WHO and Alzheimer's Disease International, while the 139 million projection applies today's age-specific rates to UN population forecasts. The Global Burden of Disease study, which uses different case definitions, produces its own higher projection of about 153 million by 2050. Neither is a census: most low-income estimates are extrapolated from a few community surveys.
What would change the projection
Projections assume age-specific risk stays constant, yet cohort studies in the UK, USA and northern Europe found that a person of a given age today is less likely to develop dementia than one a generation ago, probably because of more education and better vascular health. If that trend spreads, the 2050 total will be too high. Rising diabetes and obesity push the other way. Blood-based biomarker tests could also raise recorded prevalence by diagnosing people earlier, without any change in true risk.
Cite this page
GlobeChart. “Aging-Related Disease.” Last updated 2026-10-31. https://globechart.com/health/aging-disease/
Please also credit the original publisher named under each chart: Alzheimer's Disease International World Alzheimer Report 2024; WHO Global Dementia Observatory, ADI 2024. Spotted an error? Tell us.